TGFB1 and colorectal carcinoma: Therefore, the potential for improving chemotherapeutic efficacy in CRC patients critically depends on improving our understanding of the mechanism by which TGF-β induces EMT in CRC cells leading to chemoresistance and metastasis (Goldberg et al., 2004; Goldberg et al., 2006).